TRPharma

TRPharm is a regional pharmaceutical company headquartered in Istanbul, Turkey, focusing on the development, manufacturing, and commercialization of innovative medicines and biosimilars. The company operates across Turkey, the Middle East, North Africa (MENA), and the CIS regions, with a strong emphasis on therapeutic areas such as oncology, rheumatology, and rare diseases. TRPharm is notable for its strategic partnerships with global biotech firms to bring advanced therapies to its target markets and its investment in local biotechnological manufacturing capabilities. Their portfolio includes a mix of licensed innovative products and a robust pipeline of biosimilars. The company is particularly active in addressing diseases with high prevalence in its geographic footprint, such as Behcet's disease.